Despite AstraZeneca’s falling share price today, this writer believes the London-listed pharmaceutical giant could be worth a ...

Harvey Jones says Stocks and Shares ISA investors should consider FTSE 250 fund manager aberdeen, a recovery stock that pays ...

Harvey Jones checks analyst forecasts to see where Taylor Wimpey shares could go over the next year. They're optimistic about ...

Jon Smith explains which sectors could offer high growth potential for the coming decade and how to make the stock market ...

Associated British Food (ABF) shares have slumped on news of tough retail conditions. Is the FTSE 100 stock now too cheap to ...

BP's low-carbon aims were not a success for the share price. But we're at the start of a strategic reversal back to the old ...

The HSBC share price has wobbled in the aftermath of the escalating US-China tariff war. Can Q1 results help settle market ...

2025 looks like another lively year for shareholders of FTSE 100 and FTSE 250 companies, as rumours of another mid-cap ...

Jon Smith points out a potential passive income opportunity with a small-cap stock in the finance space that has a policy to ...

Our writer is watching one high-quality data company from the FTSE 100 index, ready to pounce if its shares tumble later this ...

Royston Wild explains how a portfolio of well-chosen FTSE 100 and FTSE 250 shares could deliver solid shareholder returns ...

The new Stocks and Shares ISA year is off to a shaky start thanks to tariff wars and financial turbulence. Don't be put off ...